Geoff Meacham
Stock Analyst at B of A Securities
(3.63)
# 788
Out of 4,876 analysts
253
Total ratings
53.12%
Success rate
4.39%
Average return
Main Sectors:
Stocks Rated by Geoff Meacham
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BBIO BridgeBio Pharma | Maintains: Buy | $50 → $54 | $45.06 | +19.84% | 6 | Jun 25, 2025 | |
| PTGX Protagonist Therapeutics | Initiates: Buy | $72 | $55.18 | +30.48% | 1 | Jun 17, 2025 | |
| NAMS NewAmsterdam Pharma Company | Initiates: Buy | $42 | $18.72 | +124.36% | 1 | Jun 17, 2025 | |
| ACLX Arcellx | Initiates: Buy | $110 | $63.92 | +72.09% | 1 | Jun 17, 2025 | |
| AMLX Amylyx Pharmaceuticals | Initiates: Buy | $12 | $6.36 | +88.68% | 2 | Jun 17, 2025 | |
| ABOS Acumen Pharmaceuticals | Initiates: Buy | $4 | $1.19 | +236.13% | 4 | Jun 17, 2025 | |
| NVAX Novavax | Initiates: Sell | $6 | $6.56 | -8.54% | 1 | Jun 17, 2025 | |
| RNA Avidity Biosciences | Maintains: Buy | $70 → $75 | $30.09 | +149.25% | 6 | Jun 10, 2025 | |
| REGN Regeneron Pharmaceuticals | Maintains: Buy | $700 → $650 | $528.10 | +23.08% | 22 | Jun 2, 2025 | |
| ABBV AbbVie | Downgrades: Neutral | $210 → $205 | $186.74 | +9.78% | 17 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $47 → $44 | $46.09 | -4.52% | 5 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $50 → $40 | $49.52 | -19.22% | 8 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $145 → $140 | $107.29 | +30.49% | 2 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $7 → $1 | $0.80 | +25.30% | 3 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $40 | $27.88 | +43.47% | 10 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $40 | $28.60 | +39.86% | 3 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $95 | $43.80 | +116.92% | 2 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $25 | $9.84 | +154.07% | 1 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $99 → $103 | $54.80 | +87.96% | 3 | Feb 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $160 → $145 | $127.82 | +13.44% | 14 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $310 → $295 | $279.87 | +5.41% | 11 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $98 → $85 | $47.08 | +80.54% | 2 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $112 → $4 | $1.98 | +102.02% | 5 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $125 | $108.45 | +15.26% | 6 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $575 | $444.77 | +29.28% | 4 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1,150 → $1,100 | $799.83 | +37.53% | 9 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $120 → $20 | $9.04 | +121.24% | 3 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $22 → $31 | $9.84 | +215.04% | 2 | Oct 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $10 | $0.37 | +2,568.09% | 2 | Aug 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $145 | $79.26 | +82.94% | 6 | Jul 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $180 → $170 | $152.49 | +11.49% | 3 | Apr 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $38 | $35.44 | +7.24% | 2 | Apr 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $48 | $23.33 | +105.74% | 2 | Mar 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $68 → $60 | $46.82 | +28.15% | 8 | Jan 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $8 | $1.20 | +566.67% | 2 | Dec 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $23 → $14 | $5.28 | +165.15% | 2 | Sep 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $10 → $8 | $5.40 | +48.29% | 4 | Aug 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $17 | $0.53 | +3,091.89% | 1 | Aug 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $50 → $45 | $24.36 | +84.73% | 6 | Apr 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $24 | $2.23 | +976.23% | 4 | Nov 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $12 → $4 | $3.35 | +19.40% | 2 | Jun 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $1.27 | +2,104.72% | 1 | Aug 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $34 | $0.57 | +5,917.70% | 1 | Jul 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $56 | $4.73 | +1,083.93% | 3 | May 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $35 | $1.03 | +3,314.63% | 4 | Jan 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $525 | $3.44 | +15,161.63% | 1 | Nov 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $42 | $1.08 | +3,788.89% | 1 | Oct 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $20 | $6.68 | +199.40% | 1 | Sep 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $20 | $0.56 | +3,493.24% | 2 | Sep 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Underperform | $9 | $3.32 | +171.08% | 1 | Jun 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $60 | $8.74 | +586.50% | 1 | Jun 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underperform | $7 | $3.86 | +81.35% | 1 | Jun 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $15 → $23 | $12.39 | +85.63% | 3 | Aug 5, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $90 → $82 | $70.73 | +15.93% | 9 | May 3, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $100 → $95 | $285.94 | -66.78% | 6 | Mar 1, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $300 → $80 | $9.35 | +755.61% | 3 | Dec 20, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $100 → $135 | $126.69 | +6.56% | 2 | Aug 1, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $6.26 | - | 4 | May 21, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $16 → $20 | $0.75 | +2,561.70% | 4 | May 3, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | n/a | $14.67 | - | 2 | Apr 5, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $127 → $158 | $317.00 | -50.16% | 5 | Nov 8, 2017 |
BridgeBio Pharma
Jun 25, 2025
Maintains: Buy
Price Target: $50 → $54
Current: $45.06
Upside: +19.84%
Protagonist Therapeutics
Jun 17, 2025
Initiates: Buy
Price Target: $72
Current: $55.18
Upside: +30.48%
NewAmsterdam Pharma Company
Jun 17, 2025
Initiates: Buy
Price Target: $42
Current: $18.72
Upside: +124.36%
Arcellx
Jun 17, 2025
Initiates: Buy
Price Target: $110
Current: $63.92
Upside: +72.09%
Amylyx Pharmaceuticals
Jun 17, 2025
Initiates: Buy
Price Target: $12
Current: $6.36
Upside: +88.68%
Acumen Pharmaceuticals
Jun 17, 2025
Initiates: Buy
Price Target: $4
Current: $1.19
Upside: +236.13%
Novavax
Jun 17, 2025
Initiates: Sell
Price Target: $6
Current: $6.56
Upside: -8.54%
Avidity Biosciences
Jun 10, 2025
Maintains: Buy
Price Target: $70 → $75
Current: $30.09
Upside: +149.25%
Regeneron Pharmaceuticals
Jun 2, 2025
Maintains: Buy
Price Target: $700 → $650
Current: $528.10
Upside: +23.08%
AbbVie
May 14, 2025
Downgrades: Neutral
Price Target: $210 → $205
Current: $186.74
Upside: +9.78%
May 12, 2025
Maintains: Neutral
Price Target: $47 → $44
Current: $46.09
Upside: -4.52%
May 7, 2025
Upgrades: Neutral
Price Target: $50 → $40
Current: $49.52
Upside: -19.22%
May 6, 2025
Maintains: Buy
Price Target: $145 → $140
Current: $107.29
Upside: +30.49%
Apr 2, 2025
Downgrades: Underperform
Price Target: $7 → $1
Current: $0.80
Upside: +25.30%
Mar 13, 2025
Initiates: Neutral
Price Target: $40
Current: $27.88
Upside: +43.47%
Mar 13, 2025
Initiates: Buy
Price Target: $40
Current: $28.60
Upside: +39.86%
Mar 13, 2025
Initiates: Buy
Price Target: $95
Current: $43.80
Upside: +116.92%
Mar 13, 2025
Initiates: Buy
Price Target: $25
Current: $9.84
Upside: +154.07%
Feb 20, 2025
Maintains: Buy
Price Target: $99 → $103
Current: $54.80
Upside: +87.96%
Feb 13, 2025
Maintains: Neutral
Price Target: $160 → $145
Current: $127.82
Upside: +13.44%
Jan 28, 2025
Maintains: Neutral
Price Target: $310 → $295
Current: $279.87
Upside: +5.41%
Jan 7, 2025
Maintains: Buy
Price Target: $98 → $85
Current: $47.08
Upside: +80.54%
Jan 7, 2025
Downgrades: Underperform
Price Target: $112 → $4
Current: $1.98
Upside: +102.02%
Nov 14, 2024
Initiates: Buy
Price Target: $125
Current: $108.45
Upside: +15.26%
Nov 14, 2024
Initiates: Buy
Price Target: $575
Current: $444.77
Upside: +29.28%
Oct 31, 2024
Maintains: Buy
Price Target: $1,150 → $1,100
Current: $799.83
Upside: +37.53%
Oct 30, 2024
Downgrades: Underperform
Price Target: $120 → $20
Current: $9.04
Upside: +121.24%
Oct 18, 2024
Upgrades: Buy
Price Target: $22 → $31
Current: $9.84
Upside: +215.04%
Aug 19, 2024
Maintains: Buy
Price Target: $12 → $10
Current: $0.37
Upside: +2,568.09%
Jul 31, 2024
Maintains: Buy
Price Target: $150 → $145
Current: $79.26
Upside: +82.94%
Apr 17, 2024
Maintains: Neutral
Price Target: $180 → $170
Current: $152.49
Upside: +11.49%
Apr 12, 2024
Maintains: Buy
Price Target: $40 → $38
Current: $35.44
Upside: +7.24%
Mar 13, 2024
Maintains: Buy
Price Target: $24 → $48
Current: $23.33
Upside: +105.74%
Jan 3, 2024
Downgrades: Neutral
Price Target: $68 → $60
Current: $46.82
Upside: +28.15%
Dec 15, 2023
Downgrades: Neutral
Price Target: $8
Current: $1.20
Upside: +566.67%
Sep 8, 2023
Downgrades: Neutral
Price Target: $23 → $14
Current: $5.28
Upside: +165.15%
Aug 21, 2023
Maintains: Underperform
Price Target: $10 → $8
Current: $5.40
Upside: +48.29%
Aug 21, 2023
Maintains: Buy
Price Target: $19 → $17
Current: $0.53
Upside: +3,091.89%
Apr 21, 2023
Maintains: Neutral
Price Target: $50 → $45
Current: $24.36
Upside: +84.73%
Nov 1, 2022
Downgrades: Underperform
Price Target: $24
Current: $2.23
Upside: +976.23%
Jun 8, 2022
Downgrades: Neutral
Price Target: $12 → $4
Current: $3.35
Upside: +19.40%
Aug 10, 2021
Initiates: Buy
Price Target: $28
Current: $1.27
Upside: +2,104.72%
Jul 13, 2021
Initiates: Buy
Price Target: $34
Current: $0.57
Upside: +5,917.70%
May 7, 2021
Upgrades: Buy
Price Target: $56
Current: $4.73
Upside: +1,083.93%
Jan 15, 2021
Downgrades: Neutral
Price Target: $35
Current: $1.03
Upside: +3,314.63%
Nov 23, 2020
Initiates: Buy
Price Target: $525
Current: $3.44
Upside: +15,161.63%
Oct 20, 2020
Initiates: Buy
Price Target: $42
Current: $1.08
Upside: +3,788.89%
Sep 15, 2020
Reinstates: Buy
Price Target: $20
Current: $6.68
Upside: +199.40%
Sep 8, 2020
Reinstates: Buy
Price Target: $20
Current: $0.56
Upside: +3,493.24%
Jun 25, 2020
Reinstates: Underperform
Price Target: $9
Current: $3.32
Upside: +171.08%
Jun 25, 2020
Reinstates: Buy
Price Target: $60
Current: $8.74
Upside: +586.50%
Jun 25, 2020
Initiates: Underperform
Price Target: $7
Current: $3.86
Upside: +81.35%
Aug 5, 2019
Maintains: Equal-Weight
Price Target: $15 → $23
Current: $12.39
Upside: +85.63%
May 3, 2019
Downgrades: Equal-Weight
Price Target: $90 → $82
Current: $70.73
Upside: +15.93%
Mar 1, 2019
Maintains: Underweight
Price Target: $100 → $95
Current: $285.94
Upside: -66.78%
Dec 20, 2018
Downgrades: Equal-Weight
Price Target: $300 → $80
Current: $9.35
Upside: +755.61%
Aug 1, 2018
Maintains: Overweight
Price Target: $100 → $135
Current: $126.69
Upside: +6.56%
May 21, 2018
Downgrades: Underweight
Price Target: n/a
Current: $6.26
Upside: -
May 3, 2018
Maintains: Equal-Weight
Price Target: $16 → $20
Current: $0.75
Upside: +2,561.70%
Apr 5, 2018
Downgrades: Equal-Weight
Price Target: n/a
Current: $14.67
Upside: -
Nov 8, 2017
Maintains: Overweight
Price Target: $127 → $158
Current: $317.00
Upside: -50.16%